Cargando…
Concomitant inpatient prescribing of strong opioids with sedatives: Associations with comorbid conditions
Co‐prescribing of opioids and sedatives is a known risk factor for opioid‐induced ventilatory impairment (OIVI). Prevalence data for sedative and opioid co‐prescription in inpatients in Australia are unknown. Our objective was to determine the prevalence of inpatient sedative and opioid co‐prescribi...
Autores principales: | Li, Ray J., Caughey, Gillian E., Shakib, Sepehr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868063/ https://www.ncbi.nlm.nih.gov/pubmed/33550717 http://dx.doi.org/10.1002/prp2.717 |
Ejemplares similares
-
Guideline Compliance in Chronic Heart Failure Patients with Multiple Comorbid Diseases: Evaluation of an Individualised Multidisciplinary Model of Care
por: Ho, Tam H., et al.
Publicado: (2014) -
Evaluation of the prescribing practice of guideline-directed medical therapy among ambulatory chronic heart failure patients
por: Parajuli, Daya Ram, et al.
Publicado: (2021) -
Influence of medication risks and benefits on treatment preferences in older patients with multimorbidity
por: Caughey, Gillian E, et al.
Publicado: (2017) -
What is polypharmacy? A systematic review of definitions
por: Masnoon, Nashwa, et al.
Publicado: (2017) -
Categorization of adverse drug reactions in electronic health records
por: Foreman, Caroline, et al.
Publicado: (2020)